C
Citius Pharmaceuticals, Inc. (CTXR)
NCM – Real Time Price. Currency in USD
0.61
-0.03 (-4.01%)
At close: May 12, 2026, 4:00 PM EDT
0.62
+0.01 (1.37%)
After-hours: May 12, 2026, 7:53 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.61
-0.03 (-4.01%)
At close: May 12, 2026, 4:00 PM EDT
0.62
+0.01 (1.37%)
After-hours: May 12, 2026, 7:53 PM EDT
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company’s late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
| Name | Position |
|---|---|
| Dr. Alan Lader Ph.D. | Senior VP and Head of Clinical Operations & Quality Assurance |
| Dr. Myron S. Czuczman M.D. | Executive VP & Chief Medical Officer |
| Mr. Dhananjay G. Wadekar | Senior Vice President of Business Strategy |
| Mr. Gary F. Talarico | Executive Vice President of Operations |
| Mr. Jaime Bartushak | Chief Business Officer & CFO |
| Mr. Kelly Creighton Ph.D. | Executive Vice President of Chemistry, Manufacturing & Controls |
| Mr. Leonard L. Mazur | Co-Founder, CEO, Chairman & Secretary |
| Mr. Myron Z. Holubiak | Co-Founder & Executive Vice Chairman |
| Mr. Nikolas Burlew | Executive Vice President of Quality Assurance |
| Ms. Ilanit Allen | Vice President of Investor Relations & Corporate Communications |
| Date | Type | Document |
|---|---|---|
| 2026-05-08 | 8-K | ea0289731-8k_citius.htm |
| 2026-04-29 | 8-K | ea0288203-8k_citius.htm |
| 2026-04-24 | 8-K | ea0287620-8k_citius.htm |
| 2026-04-06 | 8-K | ea0285222-8k_citius.htm |
| 2026-03-31 | 8-K | ea0284323-8k_citius.htm |
| 2026-03-10 | 8-K | ea0280664-8k_citius.htm |
| 2026-03-04 | 8-K | ea0277422-8k_citius.htm |
| 2026-02-24 | DEFA14A | ea02772491-defa14a_citius.htm |
| 2026-02-24 | DEF 14A | ea0277108-def14a_citius.htm |
| 2026-02-13 | 8-K | ea0276948-8k_citius.htm |